{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:17:23Z","timestamp":1783631843458,"version":"3.55.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The new wave of anti-migraine agents is nothing less than a milestone in our battle to manage this devastating disease. However, concerns have recently increased regarding the safety of these drugs. CGRP, while known as a potent vasodilator, is also a key neural and immune modulator. The roles of CGRP in immune determination, have been studied in depth, with particular focus on its functional significance with respect to common immune challenges i.e., bacterial, viral, fungal and parasitic infections. This review discusses many potential areas of concern in regard to blocking CGRP function and its potential influence on immune milieus during infection, and the risk of adverse effects. Finally, this review recommends specific measures to be taken into consideration when administering anti-CGRP\/CGRPR agents.<\/jats:p>","DOI":"10.1186\/s12967-020-02681-6","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:03:31Z","timestamp":1609967011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Anti-migraine agents from an immunological point of view"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3081-1333","authenticated-orcid":false,"given":"Mushref Bakri","family":"Assas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"5922","key":"2681_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/304129a0","volume":"304","author":"MG Rosenfeld","year":"1983","unstructured":"Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983;304(5922):129\u201335.","journal-title":"Nature"},{"issue":"5","key":"2681_CR2","first-page":"1011","volume":"48","author":"M Inaba","year":"1990","unstructured":"Inaba M, Nishizawa Y, Morii H. Tissue distribution and physiologic role of calcitonin and CGRP. Nihon Rinsho. 1990;48(5):1011\u20135.","journal-title":"Nihon Rinsho"},{"issue":"1","key":"2681_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1526-4610.2010.01799.x","volume":"51","author":"KM Connor","year":"2011","unstructured":"Connor KM, Aurora SK, Loeys T, Ashina M, Jones C, Giezek H, et al. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. Headache. 2011;51(1):73\u201384.","journal-title":"Headache"},{"issue":"4","key":"2681_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/bst0300451","volume":"30","author":"AC Conner","year":"2002","unstructured":"Conner AC, Hay DL, Howitt SG, Kilk K, Langel U, Wheatley M, et al. Interaction of calcitonin-gene-related peptide with its receptors. Biochem Soc Trans. 2002;30(4):451\u20135.","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"2681_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/13892037113149990057","volume":"14","author":"IM Dickerson","year":"2013","unstructured":"Dickerson IM. Role of CGRP-receptor component protein (RCP) in CLR\/RAMP function. Curr Protein Pept Sci. 2013;14(5):407\u201315.","journal-title":"Curr Protein Pept Sci"},{"issue":"45","key":"2681_CR6","doi-asserted-by":"publisher","first-page":"42182","DOI":"10.1074\/jbc.M107323200","volume":"276","author":"S Hilairet","year":"2001","unstructured":"Hilairet S, Belanger C, Bertrand J, Laperriere A, Foord SM, Bouvier M. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin. J Biol Chem. 2001;276(45):42182\u201390.","journal-title":"J Biol Chem"},{"issue":"11","key":"2681_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/00004647-199911000-00012","volume":"19","author":"MJ Moreno","year":"1999","unstructured":"Moreno MJ, Cohen Z, Stanimirovic DB, Hamel E. Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture. J Cereb Blood Flow Metab. 1999;19(11):1270\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2681_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0301-0082(94)E0017-B","volume":"45","author":"CA Maggi","year":"1995","unstructured":"Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol. 1995;45(1):1\u201398.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"2681_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/mi.2014.80","volume":"7","author":"BM Assas","year":"2014","unstructured":"Assas BM, Miyan JA, Pennock JL. Cross-talk between neural and immune receptors provides a potential mechanism of homeostatic regulation in the gut mucosa. Mucosal Immunol. 2014;7(6):1283\u20139.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"2681_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1021\/bi00216a036","volume":"30","author":"AL Breeze","year":"1991","unstructured":"Breeze AL, Harvey TS, Bazzo R, Campbell ID. Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics. Biochemistry. 1991;30(2):575\u201382.","journal-title":"Biochemistry"},{"issue":"6","key":"2681_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1517\/13543784.2012.681044","volume":"21","author":"A Negro","year":"2012","unstructured":"Negro A, Lionetto L, Simmaco M, Martelletti P. CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin Investig Drugs. 2012;21(6):807\u201318.","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"2681_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350(11):1104\u201310.","journal-title":"N Engl J Med"},{"issue":"2","key":"2681_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/s-0030-1249220","volume":"30","author":"MS Robbins","year":"2010","unstructured":"Robbins MS, Lipton RB. The epidemiology of primary headache disorders. Semin Neurol. 2010;30(2):107\u201319.","journal-title":"Semin Neurol"},{"issue":"5","key":"2681_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"},{"issue":"4","key":"2681_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ncl.2016.06.011","volume":"34","author":"DS Younger","year":"2016","unstructured":"Younger DS. Epidemiology of Migraine. Neurol Clin. 2016;34(4):849\u201361.","journal-title":"Neurol Clin"},{"issue":"8","key":"2681_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455\u201364.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2681_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410330109","volume":"33","author":"PJ Goadsby","year":"1993","unstructured":"Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33(1):48\u201356.","journal-title":"Ann Neurol"},{"issue":"2","key":"2681_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183\u20137.","journal-title":"Ann Neurol"},{"issue":"6","key":"2681_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies-successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338\u201350.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"2681_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1474-4422(09)70090-0","volume":"8","author":"J Olesen","year":"2009","unstructured":"Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol. 2009;8(7):679\u201390.","journal-title":"Lancet Neurol."},{"issue":"13","key":"2681_CR21","first-page":"929","volume":"75","author":"K Traynor","year":"2018","unstructured":"Traynor K. FDA approves licensing of erenumab-aooe to prevent migraine. Am J Health Syst Pharm. 2018;75(13):929\u201330.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"2681_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0333102417741297","volume":"39","author":"S Khan","year":"2019","unstructured":"Khan S, Olesen A, Ashina M. CGRP, a target for preventive therapy in migraine and cluster headache: systematic review of clinical data. Cephalalgia. 2019;39(3):374\u201389.","journal-title":"Cephalalgia"},{"issue":"11","key":"2681_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1474-4422(15)00249-5","volume":"14","author":"ME Bigal","year":"2015","unstructured":"Bigal ME, Dodick DW, Rapoport AM, Silberstein SD, Ma Y, Yang R, et al. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol. 2015;14(11):1081\u201390.","journal-title":"Lancet Neurol"},{"issue":"11","key":"2681_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(15)00245-8","volume":"14","author":"ME Bigal","year":"2015","unstructured":"Bigal ME, Edvinsson L, Rapoport AM, Lipton RB, Spierings EL, Diener HC, et al. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol. 2015;14(11):1091\u2013100.","journal-title":"Lancet Neurol"},{"issue":"4","key":"2681_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(16)00019-3","volume":"15","author":"H Sun","year":"2016","unstructured":"Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M, et al. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15(4):382\u201390.","journal-title":"Lancet Neurol"},{"issue":"11","key":"2681_CR26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, et al. Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol. 2014;13(11):1100\u20137.","journal-title":"Lancet Neurol"},{"issue":"9","key":"2681_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2014;13(9):885\u201392.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2681_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","volume":"18","author":"M Deen","year":"2017","unstructured":"Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltran E, et al. Blocking CGRP in migraine patients-a review of pros and cons. J Headache Pain. 2017;18(1):96.","journal-title":"J Headache Pain."},{"issue":"1","key":"2681_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-018-0927-2","volume":"19","author":"CE Christensen","year":"2018","unstructured":"Christensen CE, Younis S, Deen M, Khan S, Ghanizada H, Ashina M. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials. J Headache Pain. 2018;19(1):105.","journal-title":"J Headache Pain"},{"issue":"6425","key":"2681_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/363159a0","volume":"363","author":"J Hosoi","year":"1993","unstructured":"Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature. 1993;363(6425):159\u201363.","journal-title":"Nature"},{"issue":"3","key":"2681_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/imm.12562","volume":"147","author":"BM Assas","year":"2016","unstructured":"Assas BM, Wakid MH, Zakai HA, Miyan JA, Pennock JL. Transient receptor potential vanilloid 1 expression and function in splenic dendritic cells: a potential role in immune homeostasis. Immunology. 2016;147(3):292\u2013304.","journal-title":"Immunology"},{"issue":"4","key":"2681_CR32","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/ibd.21422","volume":"17","author":"MA Engel","year":"2011","unstructured":"Engel MA, Becker C, Reeh PW, Neurath MF. Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut. Inflamm Bowel Dis. 2011;17(4):1030\u20133.","journal-title":"Inflamm Bowel Dis"},{"key":"2681_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1749-6632.1994.tb23112.x","volume":"741","author":"JE Blalock","year":"1994","unstructured":"Blalock JE. Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Ann N Y Acad Sci. 1994;741:292\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2681_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/cimm.2001.1795","volume":"209","author":"S Fernandez","year":"2001","unstructured":"Fernandez S, Knopf MA, Bjork SK, McGillis JP. Bone marrow-derived macrophages express functional CGRP receptors and respond to CGRP by increasing transcription of c-fos and IL-6 mRNA. Cell Immunol. 2001;209(2):140\u20138.","journal-title":"Cell Immunol"},{"issue":"1","key":"2681_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4049\/jimmunol.179.1.607","volume":"179","author":"MD Harzenetter","year":"2007","unstructured":"Harzenetter MD, Novotny AR, Gais P, Molina CA, Altmayr F, Holzmann B. Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER. J Immunol. 2007;179(1):607\u201315.","journal-title":"J Immunol"},{"key":"2681_CR36","first-page":"213","volume":"15","author":"O Bauer","year":"2000","unstructured":"Bauer O, Razin E. Mast Cell-Nerve Interactions. News Physiol Sci. 2000;15:213\u20138.","journal-title":"News Physiol Sci"},{"issue":"1","key":"2681_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00318146","volume":"265","author":"MG Blennerhassett","year":"1991","unstructured":"Blennerhassett MG, Tomioka M, Bienenstock J. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res. 1991;265(1):121\u20138.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2681_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(SICI)1097-4695(199805)35:2<173::AID-NEU4>3.0.CO;2-1","volume":"35","author":"MG Blennerhassett","year":"1998","unstructured":"Blennerhassett MG, Bienenstock J. Sympathetic nerve contact causes maturation of mast cells in vitro. J Neurobiol. 1998;35(2):173\u201382.","journal-title":"J Neurobiol"},{"issue":"2","key":"2681_CR39","first-page":"242","volume":"107","author":"A Asahina","year":"1995","unstructured":"Asahina A, Hosoi J, Murphy GF, Granstein RD. Calcitonin gene-related peptide modulates Langerhans cell antigen-presenting function. Proc Assoc Am Physicians. 1995;107(2):242\u20134.","journal-title":"Proc Assoc Am Physicians"},{"issue":"18","key":"2681_CR40","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.1073\/pnas.92.18.8323","volume":"92","author":"A Asahina","year":"1995","unstructured":"Asahina A, Moro O, Hosoi J, Lerner EA, Xu S, Takashima A, et al. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc Natl Acad Sci USA. 1995;92(18):8323\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6 Pt 2","key":"2681_CR41","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0091-6749(95)70203-2","volume":"96","author":"A Asahina","year":"1995","unstructured":"Asahina A, Hosoi J, Grabbe S, Granstein RD. Modulation of Langerhans cell function by epidermal nerves. J Allergy Clin Immunol. 1995;96(6 Pt 2):1178\u201382.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2681_CR42","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.4049\/jimmunol.166.4.2167","volume":"166","author":"S Dunzendorfer","year":"2001","unstructured":"Dunzendorfer S, Kaser A, Meierhofer C, Tilg H, Wiedermann CJ. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol. 2001;166(4):2167\u201372.","journal-title":"J Immunol"},{"issue":"6","key":"2681_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ni1078","volume":"5","author":"L Steinman","year":"2004","unstructured":"Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol. 2004;5(6):575\u201381.","journal-title":"Nat Immunol"},{"issue":"21","key":"2681_CR44","doi-asserted-by":"publisher","first-page":"12544","DOI":"10.1073\/pnas.95.21.12544","volume":"95","author":"M Levite","year":"1998","unstructured":"Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA. 1998;95(21):12544\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2681_CR45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0167-5699(94)90205-4","volume":"15","author":"JE Blalock","year":"1994","unstructured":"Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today. 1994;15(11):504\u201311.","journal-title":"Immunol Today"},{"issue":"1\u20132","key":"2681_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(02)00221-7","volume":"130","author":"H Wang","year":"2002","unstructured":"Wang H, Xing L, Li W, Hou L, Guo J, Wang X. Production and secretion of calcitonin gene-related peptide from human lymphocytes. J Neuroimmunol. 2002;130(1\u20132):155\u201362.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2681_CR47","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.4049\/jimmunol.135.4.2569","volume":"135","author":"M Rola-Pleszczynski","year":"1985","unstructured":"Rola-Pleszczynski M, Bolduc D, St-Pierre S. The effects of vasoactive intestinal peptide on human natural killer cell function. J Immunol. 1985;135(4):2569\u201373.","journal-title":"J Immunol"},{"issue":"4","key":"2681_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/brbi.1997.0499","volume":"11","author":"RJ Benschop","year":"1997","unstructured":"Benschop RJ, Schedlowski M, Wienecke H, Jacobs R, Schmidt RE. Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun. 1997;11(4):321\u201332.","journal-title":"Brain Behav Immun"},{"key":"2681_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnins.2014.00023","volume":"8","author":"BM Assas","year":"2014","unstructured":"Assas BM, Pennock JI, Miyan JA. Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Front Neurosci. 2014;8:23.","journal-title":"Front Neurosci"},{"issue":"12","key":"2681_CR50","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.4049\/jimmunol.1100028","volume":"186","author":"N Mikami","year":"2011","unstructured":"Mikami N, Matsushita H, Kato T, Kawasaki R, Sawazaki T, Kishimoto T, et al. Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functions. J Immunol. 2011;186(12):6886\u201393.","journal-title":"J Immunol"},{"issue":"1","key":"2681_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/1523-1747.ep12285627","volume":"108","author":"FE Fox","year":"1997","unstructured":"Fox FE, Kubin M, Cassin M, Niu Z, Hosoi J, Torii H, et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol. 1997;108(1):43\u20138.","journal-title":"J Invest Dermatol"},{"key":"2681_CR52","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.virol.2015.03.046","volume":"482","author":"JM Guedon","year":"2015","unstructured":"Guedon JM, Yee MB, Zhang M, Harvey SA, Goins WF, Kinchington PR. Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia. Virology. 2015;482:167\u201380.","journal-title":"Virology"},{"issue":"4","key":"2681_CR53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejpain.2008.05.011","volume":"13","author":"K Maratou","year":"2009","unstructured":"Maratou K, Wallace VC, Hasnie FS, Okuse K, Hosseini R, Jina N, et al. Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur J Pain. 2009;13(4):387\u201398.","journal-title":"Eur J Pain"},{"issue":"12","key":"2681_CR54","doi-asserted-by":"publisher","first-page":"e83603","DOI":"10.1371\/journal.pone.0083603","volume":"8","author":"SE Flowerdew","year":"2013","unstructured":"Flowerdew SE, Wick D, Himmelein S, Horn AK, Sinicina I, Strupp M, et al. Characterization of neuronal populations in the human trigeminal ganglion and their association with latent herpes simplex virus-1 infection. PLoS ONE. 2013;8(12):e83603.","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"2681_CR55","first-page":"77A","volume":"11","author":"R Itzhaki","year":"2004","unstructured":"Itzhaki R. Herpes simplex virus type 1, apolipoprotein E and Alzheimer\u2019 disease. Herpes. 2004;11(Suppl 2):77A\u201382A.","journal-title":"Herpes"},{"key":"2681_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jns.2017.06.046","volume":"380","author":"RF Itzhaki","year":"2017","unstructured":"Itzhaki RF, Tabet N. Herpes simplex encephalitis and Alzheimer\u2019s disease: is there a link? J Neurol Sci. 2017;380:20\u20131.","journal-title":"J Neurol Sci"},{"issue":"2","key":"2681_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-180266","volume":"64","author":"RF Itzhaki","year":"2018","unstructured":"Itzhaki RF, Lathe R. Herpes Viruses and Senile Dementia: first Population Evidence for a Causal Link. J Alzheimers Dis. 2018;64(2):363\u20136.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2681_CR58","first-page":"95","volume":"2","author":"R Yaraee","year":"2003","unstructured":"Yaraee R, Ebtekar M, Ahmadiani A, Sabahi F. Neuropeptides (sp and CGRP) augment IL-1 Beta production in hsv-infected macrophages. Iran J Allergy Asthma Immunol. 2003;2(2):95\u2013100.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"2681_CR59","doi-asserted-by":"crossref","unstructured":"Bomsel M, Ganor Y. Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells. J Virol. 2017;91(23).","DOI":"10.1128\/JVI.01205-17"},{"issue":"2","key":"2681_CR60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/apha.12366","volume":"213","author":"Y Ganor","year":"2015","unstructured":"Ganor Y, Drillet-Dangeard AS, Bomsel M. Calcitonin gene-related peptide inhibits human immunodeficiency type 1 transmission by Langerhans cells via an autocrine\/paracrine feedback mechanism. Acta Physiol. 2015;213(2):432\u201341.","journal-title":"Acta Physiol"},{"issue":"1","key":"2681_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/aid.2018.0210","volume":"35","author":"M Bomsel","year":"2019","unstructured":"Bomsel M, Lopalco L, Uberti-Foppa C, Siracusano G, Ganor Y. Short communication: decreased plasma calcitonin gene-related peptide as a novel biomarker for HIV-1 disease progression. AIDS Res Hum Retroviruses. 2019;35(1):52\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1\u20132","key":"2681_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jneuroim.2008.05.014","volume":"200","author":"IA El Karim","year":"2008","unstructured":"El Karim IA, Linden GJ, Orr DF, Lundy FT. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol. 2008;200(1\u20132):11\u20136.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2681_CR63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0022-2143(96)80011-4","volume":"128","author":"M Lyte","year":"1996","unstructured":"Lyte M, Arulanandam BP, Frank CD. Production of Shiga-like toxins by Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone norepinephrine. J Lab Clin Med. 1996;128(4):392\u20138.","journal-title":"J Lab Clin Med"},{"issue":"4","key":"2681_CR64","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/0196-9781(90)90171-Z","volume":"11","author":"GW Bernard","year":"1990","unstructured":"Bernard GW, Shih C. The osteogenic stimulating effect of neuroactive calcitonin gene-related peptide. Peptides. 1990;11(4):625\u201332.","journal-title":"Peptides"},{"key":"2681_CR65","doi-asserted-by":"publisher","first-page":"35379","DOI":"10.1038\/srep35379","volume":"6","author":"AR N\u2019Diaye","year":"2016","unstructured":"N\u2019Diaye AR, Leclerc C, Kentache T, Hardouin J, Poc CD, Konto-Ghiorghi Y, et al. Skin-bacteria communication: involvement of the neurohormone Calcitonin Gene Related Peptide (CGRP) in the regulation of Staphylococcus epidermidis virulence. Sci Rep. 2016;6:35379.","journal-title":"Sci Rep"},{"issue":"5","key":"2681_CR66","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","volume":"43","author":"TC Scharschmidt","year":"2015","unstructured":"Scharschmidt TC, Vasquez KS, Truong HA, Gearty SV, Pauli ML, Nosbaum A, et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity. 2015;43(5):1011\u201321.","journal-title":"Immunity"},{"key":"2681_CR67","doi-asserted-by":"crossref","unstructured":"Pinho-Ribeiro FA, Baddal B, Haarsma R, O\u2019Seaghdha M, Yang NJ, Blake KJ, et al. Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection. Cell. 2018;173(5):1083-97 e22.","DOI":"10.1016\/j.cell.2018.04.006"},{"issue":"9","key":"2681_CR68","doi-asserted-by":"publisher","first-page":"e1007279","DOI":"10.1371\/journal.ppat.1007279","volume":"14","author":"O Benguettat","year":"2018","unstructured":"Benguettat O, Jneid R, Soltys J, Loudhaief R, Brun-Barale A, Osman D, et al. The DH31\/CGRP enteroendocrine peptide triggers intestinal contractions favoring the elimination of opportunistic bacteria. PLoS Pathog. 2018;14(9):e1007279.","journal-title":"PLoS Pathog"},{"key":"2681_CR69","doi-asserted-by":"publisher","first-page":"4847205","DOI":"10.1155\/2018\/4847205","volume":"2018","author":"D Augustyniak","year":"2018","unstructured":"Augustyniak D, Roszkowiak J, Wisniewska I, Skala J, Gorczyca D, Drulis-Kawa Z. Neuropeptides SP and CGRP Diminish the Moraxella catarrhalis Outer Membrane Vesicle- (OMV-) Triggered Inflammatory Response of Human A549 Epithelial Cells and Neutrophils. Mediators Inflamm. 2018;2018:4847205.","journal-title":"Mediators Inflamm"},{"issue":"12","key":"2681_CR70","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/asj.13115","volume":"89","author":"F Namai","year":"2018","unstructured":"Namai F, Yamamoto Y, Sato T, Ogita T, Shimosato T. Recombinant mouse calcitonin gene-related peptide secreted by Lactococcus lactis inhibits lipopolysaccharide-induced inflammatory response in macrophages. Anim Sci J. 2018;89(12):1707\u201311.","journal-title":"Anim Sci J"},{"issue":"2","key":"2681_CR71","first-page":"3246","volume":"17","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zhang H, Zhang G, He Y, Zhang P, Sun Z, et al. Calcitonin generelated peptide reduces Porphyromonas gingivalis LPSinduced TNFalpha release and apoptosis in osteoblasts. Mol Med Rep. 2018;17(2):3246\u201354.","journal-title":"Mol Med Rep"},{"issue":"6","key":"2681_CR72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00418-003-0532-5","volume":"119","author":"F De Jonge","year":"2003","unstructured":"De Jonge F, Van Nassauw L, Adriaensen D, Van Meir F, Miller HR, Van Marck E, et al. Effect of intestinal inflammation on capsaicin-sensitive afferents in the ileum of Schistosoma mansoni-infected mice. Histochem Cell Biol. 2003;119(6):477\u201384.","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"2681_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3940(98)00236-5","volume":"246","author":"AA Ahmed","year":"1998","unstructured":"Ahmed AA, Ahmed M, Theodorsson E, Nordlind K. Decreased concentrations of CGRP in Leishmania major murine cutaneous leishmaniasis. Neurosci Lett. 1998;246(3):149\u201352.","journal-title":"Neurosci Lett"},{"issue":"1","key":"2681_CR74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-3083.1998.00380.x","volume":"48","author":"AA Ahmed","year":"1998","unstructured":"Ahmed AA, Wahbi A, Nordlind K, Kharazmi A, Sundqvist KG, Mutt V, et al. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand J Immunol. 1998;48(1):79\u201385.","journal-title":"Scand J Immunol"},{"issue":"4","key":"2681_CR75","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1046\/j.1365-2133.2003.05604.x","volume":"149","author":"MR Ruiz","year":"2003","unstructured":"Ruiz MR, Quinones AG, Diaz NL, Tapia FJ. Acute immobilization stress induces clinical and neuroimmunological alterations in experimental murine cutaneous leishmaniasis. Br J Dermatol. 2003;149(4):731\u20138.","journal-title":"Br J Dermatol"},{"key":"2681_CR76","doi-asserted-by":"crossref","unstructured":"Levite M. Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann N Y Acad Sci. 2000;917:307-21.","DOI":"10.1111\/j.1749-6632.2000.tb05397.x"},{"issue":"1","key":"2681_CR77","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10194-019-1043-7","volume":"20","author":"AM Harriott","year":"2019","unstructured":"Harriott AM, Strother LC, Vila-Pueyo M, Holland PR. Animal models of migraine and experimental techniques used to examine trigeminal sensory processing. J Headache Pain. 2019;20(1):91.","journal-title":"J Headache Pain"},{"issue":"7","key":"2681_CR78","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/bjp.2008.334","volume":"155","author":"J Zeller","year":"2008","unstructured":"Zeller J, Poulsen KT, Sutton JE, Abdiche YN, Collier S, Chopra R, et al. CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. Br J Pharmacol. 2008;155(7):1093\u2013103.","journal-title":"Br J Pharmacol"},{"issue":"7 Pt 1","key":"2681_CR79","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ajh\/4.7.565","volume":"4","author":"S Schifter","year":"1991","unstructured":"Schifter S, Krusell LR, Sehested J. Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension. Am J Hypertens. 1991;4(7 Pt 1):565\u20139.","journal-title":"Am J Hypertens"},{"key":"2681_CR80","doi-asserted-by":"crossref","unstructured":"Evans RW. Raynaud\u2019s Phenomenon Associated With Calcitonin Gene-Related Peptide Monoclonal Antibody Antagonists. Headache. 2019.","DOI":"10.1111\/head.13596"},{"key":"2681_CR81","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.yrtph.2019.05.013","volume":"106","author":"JL Bussiere","year":"2019","unstructured":"Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM, et al. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine. Regul Toxicol Pharmacol. 2019;106:224\u201338.","journal-title":"Regul Toxicol Pharmacol"},{"key":"2681_CR82","doi-asserted-by":"crossref","unstructured":"Bigal ME, Walter S, Rapoport AM. Fremanezumab as a preventive treatment for episodic and chronic migraine. Expert Rev Neurother. 2019.","DOI":"10.1080\/14737175.2019.1614742"},{"key":"2681_CR83","doi-asserted-by":"crossref","unstructured":"Giannouchos TV, Mitsikostas DD, Ohsfeldt RL, Vozikis A, Koufopoulou P. Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece. Clin Drug Investig. 2019.","DOI":"10.1007\/s40261-019-00827-z"},{"issue":"8","key":"2681_CR84","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/14737175.2019.1621749","volume":"19","author":"A Negro","year":"2019","unstructured":"Negro A, Martelletti P. Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies. Expert Rev Neurother. 2019;19(8):769\u201376.","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"2681_CR85","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1046\/j.1468-2982.1995.1504272.x","volume":"15","author":"L Edvinsson","year":"1995","unstructured":"Edvinsson L, Goadsby PJ. Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia. 1995;15(4):272\u20136.","journal-title":"Cephalalgia"},{"issue":"1","key":"2681_CR86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0014-2999(97)83028-2","volume":"328","author":"DJ Williamson","year":"1997","unstructured":"Williamson DJ, Shepheard SL, Hill RG, Hargreaves RJ. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur J Pharmacol. 1997;328(1):61\u20134.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2681_CR87","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1523\/JNEUROSCI.19-09-03423.1999","volume":"19","author":"PL Durham","year":"1999","unstructured":"Durham PL, Russo AF. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci. 1999;19(9):3423\u20139.","journal-title":"J Neurosci"},{"issue":"2","key":"2681_CR88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1590\/0004-282x20190004","volume":"77","author":"AV Krymchantowski","year":"2019","unstructured":"Krymchantowski AV, Krymchantowski AGF, Jevoux CDC. Migraine treatment: the doors for the future are open, but with caution and prudence. Arq Neuropsiquiatr. 2019;77(2):115\u201321.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"2681_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tips.2018.11.003","volume":"40","author":"M Majima","year":"2019","unstructured":"Majima M, Ito Y, Hosono K, Amano H. CGRP\/CGRP receptor antibodies: potential adverse effects due to blockade of neovascularization? Trends Pharmacol Sci. 2019;40(1):11\u201321.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"2681_CR90","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/head.13589","volume":"59","author":"Robbins L Erenumab","year":"2019","unstructured":"Robbins L. Erenumab side effects. Headache. 2019;59(7):1088-9.","journal-title":"Headache"},{"issue":"9","key":"2681_CR91","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/head.13408","volume":"58","author":"L Robbins","year":"2018","unstructured":"Robbins L. CGRP antagonists: physiologic effects and serious side effects. Headache. 2018;58(9):1469\u201371.","journal-title":"Headache"},{"key":"2681_CR92","unstructured":"In brief: Erenumab (Aimovig) hypersensitivity. Med Lett Drugs Ther. 2019;61(1568):48."}],"updated-by":[{"DOI":"10.1186\/s12967-021-02988-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02681-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02681-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02681-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T18:13:12Z","timestamp":1674843192000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02681-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2681"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02681-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12967-021-02988-y","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12967-021-02988-y","URL":"https:\/\/doi.org\/10.1186\/s12967-021-02988-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}